fifty-seven of 66 patients with metastatic renal cell carcinoma ( rcc ) were evaluable for response after treatment with interferon ( ifn ) - alfa 2a ( roferon a , roche ) with or without vinblastine ( vb ) .
C0021747
interferon
C0021734
ifn